天津科学技术出版社
体外红细胞生成研究进展
罗乐乐 1,2,董弈 1,2,肖思衡 1,2,宋昊泽 1,2,高程杰 1,2 *,石莉红 1,2 *
作者信息
  1. 1 中国医学科学院血液病医院(中国医学科学院血液学研究所),血液与健康全国重点实验室,国家血液系统疾病临床医学研究中心,细胞生态海河实验室,天津 300020
  2. 2 天津医学健康研究院,天津 301600
*通信作者

摘要

在全球血液供应短缺、储存损伤与输血安全等问题日益突出的背景下,体外红细胞生成被视为极具前景的解决方案。 传统方法依赖造血干/ 祖细胞的红系定向分化,但其有限增殖能力制约了规模化应用。 人多能干细胞(包括胚胎干细胞和诱导多能干细胞)因其无限自我更新能力与易获得性,为红细胞大规模生成提供了更优的起始细胞来源。 此外,基因编辑与生物反应器系统的发展,也为实现高效、规模化的红细胞体外生产提供了关键支持。 系统总结不同技术路径的研究进展,着重探讨其在推动红细胞终末成熟、提升脱核率及实现规模化生产方面面临的挑战与策略,旨在为构建安全、充足、可控的未来血液供应体系提供参考。

Research advances on erythropoiesis in vitro
Lele LUO 1,2, Yi DONG 1,2, Siheng XIAO 1,2, Haoze SONG 1,2, Chengjie GAO 1,2 *, Lihong SHI 1,2 *
Author Information
  1. 1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
  2. 2 Tianjin Institutes of Health Science, Tianjin 301600, China
*Corresponding author

Abstract

To address the increasing global challenges such as blood supply shortages,storage related damage, and transfusion safety, in vitro generation of red blood cells (RBCs) is regarded as a highly promising solution. Traditional strategies using hematopoietic stem and progenitor cells (HSPC) for erythroid differentiation are constrained in scale due to their restricted proliferative capacity. Human pluripotent stem cells (hPSC), including human embryonic stem cells ( hESC) and induced pluripotent stem cells ( iPSC),have emerged as attractive differentiation sources for large-scale RBC production due to the robust expansion potential and abundant availability. Moreover, advances in genetic editing and bioreactor systems provide critical support for achieving scalable in vitro RBC production. In this review, we summarize different methodologies to generate erythrocytes in vitro and address the challenges in achieving terminal maturation, improving enucleation efficiency, and advancing toward scalable manufacturing, with the goal of providing a reference for building a safe, sufficient, and controllable blood supply system.
利益冲突:作者均声明无利益冲突

再生医学研究 Copyright © 2026. All Rights Reserved